1. Home
  2. MYGN vs BHK Comparison

MYGN vs BHK Comparison

Compare MYGN & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.44

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

Logo Blackrock Core Bond Trust

BHK

Blackrock Core Bond Trust

N/A

Current Price

$8.19

Market Cap

621.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
BHK
Founded
1991
2001
Country
United States
United States
Employees
2700
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
523.7M
621.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
BHK
Price
$5.44
$8.19
Analyst Decision
Hold
Analyst Count
9
0
Target Price
★ $5.90
N/A
AVG Volume (30 Days)
★ 1.7M
329.9K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
★ 8.34%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.03
Revenue
★ $771,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$7.99
Revenue Growth
★ 2.33
N/A
52 Week Low
$2.74
$8.03
52 Week High
$8.09
$9.72

Technical Indicators

Market Signals
Indicator
MYGN
BHK
Relative Strength Index (RSI) 46.99 36.82
Support Level $4.19 N/A
Resistance Level $5.52 $9.16
Average True Range (ATR) 0.30 0.11
MACD -0.13 -0.04
Stochastic Oscillator 0.00 1.65

Price Performance

Historical Comparison
MYGN
BHK

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About BHK Blackrock Core Bond Trust

Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.

Share on Social Networks: